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Background:  Cholera toxin from Vibrio cholerae and the type I heat-labile
enterotoxins (LT-Is) from Escherichia coli are oligomeric proteins with AB5
structures. The type II heat-labile enterotoxins (LT-IIs) from E. coli are structurally
similar to, but antigenically distinct from, the type I enterotoxins. The A subunits
of type I and type II enterotoxins are homologous and activate adenylate cyclase
by ADP-ribosylation of a G protein subunit, Gsa. However, the B subunits of type
I and type II enterotoxins differ dramatically in amino acid sequence and
ganglioside-binding specificity. The structure of LT-IIb was determined both as a
prototype for other LT-IIs and to provide additional insights into
structure/function relationships among members of the heat-labile enterotoxin
family and the superfamily of ADP-ribosylating protein toxins.
Results:  The 2.25 Å crystal structure of the LT-IIb holotoxin has been
determined. The structure reveals striking similarities with LT-I in both the
catalytic A subunit and the ganglioside-binding B subunits. The latter form a
pentamer which has a central pore with a diameter of 10–18 Å. Despite their
similarities, the relative orientation between the A polypeptide and the B
pentamer differs by 24° in LT-I and LT-IIb. A common hydrophobic ring was
observed at the A–B5 interface which may be important in the cholera toxin
family for assembly of the AB5 heterohexamer. A cluster of arginine residues at
the surface of the A subunit of LT-I and cholera toxin, possibly involved in
assembly, is also present in LT-IIb. The ganglioside receptor binding sites are
localized, as suggested by mutagenesis, and are in a position roughly similar to
the sites where LT-I binds its receptor. 
Conclusions:  The structure of LT-IIb provides insight into the sequence diversity
and structural similarity of the AB5 toxin family. New knowledge has been gained
regarding the assembly of AB5 toxins and their active-site architecture.
Introduction
Escherichia coli heat-labile enterotoxins (LTs) are closely
related to cholera toxin (CT) in both structure and modes
of action [1,2]. Both toxins act on intestinal epithelial cells,
causing a diarrheal disease in humans. They belong to the
AB class of bacterial toxins and have an AB5 structure. The
A subunit of LT and CT catalyzes the ADP-ribosylation of
a G protein subunit, Gsa, and their B subunits form a penta-
mer responsible for the recognition of the specific ganglio-
side receptors. After binding to the ganglioside receptor on
the epithelial cells, the A subunit is endocytosed. Inside
the cell the A1 subunit ADP-ribosylates the a subunit of
the heterotrimeric G-protein Gs. In order to become fully
active, the A subunit needs to be proteolytically cleaved
and reduced, resulting in an active A1 subunit and a
smaller 45-residue A2 ‘linker’ which is responsible for asso-
ciating the A subunit and the B pentamer. 
The crystal structures of both the type I heat-labile
enterotoxin (LT-I) and the very similar CT have been
determined, revealing a doughnut-shaped B pentamer, a
wedge-shaped A1 subunit and an A2 linker holding on to
the B pentamer by penetrating its pore [3–8]. Unlike LT-I
and CT, type II heat-labile enterotoxins (LT-IIa and LT-
IIb) were isolated and characterized more recently [9–11].
LT-II-producing E. coli can be isolated from cows, buffalo,
and pigs, but rarely from humans [12–14]. Interestingly,
LT-IIs are 25–50-fold more toxic to Y1 mouse adrenal
tumor cells than LT-I, although they are not active in the
in vivo rabbit ligated ileal segment assay [15,16]. LT-IIs
have been shown to bind to intestinal cells [17], but their
role in pathogenesis of infectious diseases caused by E. coli
remains to be established. 
LT-IIs share many features with LT-I and CT. These
include the AB5 architecture and the ability to activate
adenylate cyclase by ADP-ribosylating the same target, the
G-protein subunit Gsa [18,19]. The amino acid sequence
of the catalytic A1 subunits of LT-IIa and LT-IIb are 85%
identical, and share about 63% sequence identity with LT-I.
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However, the A2 linkers share only 38% sequence identity
between LT-IIa and LT-IIb and have only 21% sequence
identity with LT-I [10,11]. The B subunits  of LT-IIa and
LT-IIb show 58% sequence identity to each other;
however, they show no detectable sequence similarity to
the LT-I B subunit. This is also reflected in the fact that
LT-IIa and LT-IIb have been shown to have different
ganglioside specificities from LT-I. LT-IIb binds to gan-
gliosides GD1a and GT1b and weakly to GM3. LT-IIa binds a
larger variety of gangliosides, with the highest affinity for
GD1b, followed by GD1a, GT1b, GQ1b, GM1, GD2, GM2, and
GM3 [20]. Interestingly, all the listed gangliosides which
bind to LT-IIa and LT-IIb are able to suppress an immune
response in humans by inhibiting T-cell responses. Tumor
cells shed these gangliosides from their surfaces creating a
highly immunosuppressive microenvironment [21]. Several
of these gangliosides (GD2, GM2 and GM3) have been used
as targets for cancer therapy using monoclonal antibodies
and/or for active specific immunotherapy with vaccines
[22,23]. Heat-labile enterotoxins are not the only molecules
to make use of gangliosides for recognition of their target
cells: botulinum A neurotoxin recognizes GT1b and GD1a
[24] and the Sendai virus can use GD1a as a receptor [25]. 
We have determined the crystal structure of LT-IIb at
2.25 Å resolution. Although its role in pathogenesis of
infectious diarrheal diseases in humans or animals remains
to be established, the LT-IIb structure can aid elucidation
of common features in the interactions between the A
subunit and the B pentamer in the cholera toxin family.
This LT-IIb structure further increases our understanding
of the still unknown catalytic mechanism of ADP-ribosy-
lating toxins. The structure may also provide new insights
into the special characteristics of type II enterotoxins,
such as their increased toxicity for mouse Y1 adrenal
tumor cells [15] and their ability to bind to several cancer-
associated gangliosides [22,23]. 
Results and discussion
Structure determination
The structure of LT-IIb was determined in a non-stan-
dard way using a combination of a single isomorphous
K2PtCl4 derivative (Table 1), a homology model of the A1
and A2 subunits, and exploitation of the fivefold non-crys-
tallographic symmetry present in the B pentamer. An
initial 5 Å single isomorphous replacement (SIR) electron-
density map revealed the presence of five rods along a
fivefold axis (Fig. 1a). These rods could be superimposed
onto the five long a helices of the B pentamer of LT-I,
giving a first indication of structural similarity between
LT-IIb and LT-I. A sixth long rod representing the long
A2 helix was also clearly visible in the same SIR map (Fig.
1a). Solvent flattening, histogram matching, phase exten-
sion, and fivefold averaging improved the electron density
within the B pentamer sufficiently for model building. For
the A subunit, an initial homology model was built using
the LT-I structure as a starting point. This A-subunit
model could be placed in the asymmetric unit because the
roughly triangular shape of the A subunit and the location
of the A2 helix could be used to guide manual positioning
in the 5 Å electron-density map. Rigid-body refinement in
X-PLOR [26] followed by conventional refinement and
several rounds of model building resulted in an R-factor of
19.1% for data from 10.0–2.25 Å resolution (Table 2). 
Figure 1b shows a typical portion of the final 2Fo–Fc map
calculated using data from 20–2.25 Å resolution. The final
model includes residues 1–98 of each B subunit, residues
1–46 and 48–187 of the A1 subunit and residues 195–230 of
the A2 linker. The C-terminal Glu99 in each of the five 
B subunits is disordered and thus not included. Residues
188–194, comprising the putative cleavage site in the A-
subunit analogues to LT-I, could not be located in the elec-
tron-density map. Residue Ala47 in the A subunit was too
disordered to be modeled properly and is thus not included
in the model. In addition, the C-terminal residues 231–243
of the A2 chain could not be traced. However, substantial
yet uninterpretable electron density in the pore persists in
Fo–Fc maps contoured at the 2s level, indicating a partially
disordered conformation for these terminal residues. 
Overall structure
The structure of LT-IIb is very similar to LT-I (Figs 2,3).
The catalytic A subunit adopts the same fold in the two
toxins with a characteristic wedge-shaped structure. The
A subunit sits on top of the ring-like B pentamer. The B
subunits follow the fivefold symmetry almost perfectly
and are virtually identical to each other, as will be
described in more detail below. Along the side of the A1
subunit ‘rests’ the A2 subunit as one long helix. This A2
helix penetrates the pore of the B pentamer and continues
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Table 1
X-ray data collection statistics.
Native 1 K2PtCl4 Native 2
Diffraction limit (Å) 2.5 3.3 2.25
Completeness (%) (final shell) 85 (65) 67 (44) 83 (68)
Rmerge* (%) 7.9 11.8 6.3
Riso† (%) (15–4 Å) – 14.8
Phasing power‡ (10–5 Å)
acentric – 1.7
centric – 1.4
Rcullis§ (%) (10–5 Å)
acentric – 0.71
centric – 0.56
Number of sites – 7
*Rmerge=S|I–<I>|/ SI. †Riso=S|FPH–FP|/ SFP. ‡Phasing power=root
mean square (rms) fH/E, where fH=calculated heavy-atom structure-
factor amplitude and E=lack of closure=S||FPH±FP|–fH|, where
FPH=structure-factor amplitude of the derivative crystal and
FP=structure-factor amplitude of the native crystal. §Rcullis=lack of
closure/isomorphous difference.
to about halfway down the pore. The A2 linker provides
almost all the interactions between the A subunit and the
pentamer. The A1 subunit does not make many direct
interactions with the B pentamer, except for Arg145,
which participates in three hydrogen bonds. The LT-I A1
subunit makes more interactions by means of Arg33,
Arg148 and Arg151, which are involved in salt bridges
with the pentamer. Concerning the loop in the A1 subunit
near residue 145, it has been shown in LT-I that four
arginines located between residues 141 and 148 are impor-
tant for AB5 formation, although each individual arginine
can be mutated without any noticeable effect [27]. In the
LT-IIb sequence there are also four arginine residues
(although one of them is not in the equivalent position),
confirming their importance. Interestingly, the orientation
of the A subunit with respect to the B pentamer is quite
different in the two enterotoxins. A rotation of 24° has to
be applied to the A subunit of LT-IIb for it to have the
same relative orientation, with respect to its B pentamer,
as in LT-I. A variable A/B5 orientation is also observed in
different crystal forms of LT-I [28]. Not only the orienta-
tion but also the mode of association between the A2
subunit and the B pentamer in LT-IIb are distinctly dif-
ferent from those for LT-I, and these will be discussed
below in more detail. 
Unlike diphtheria toxin (DT) and Pseudomonas aeruginosa
exotoxin A (ETA), the membrane translocation of CT
does not require entry into acidic vesicles [29], although
earlier reports suggested such an acid-triggered mechanism
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Figure 1
Electron-density maps of LT-IIb. (a) A stereo
diagram showing a 5 Å SIR electron-density
map. This map is contoured at 1.5s and
reveals five long rods representing the helices
around the pore of the pentamer of LT-IIb.
Part of the A2 helix in the middle of the pore is
also visible. The superimposed ribbon tracings
are of the final LT-IIb structure. (b) Final
2Fo–Fc map contoured at 1.5s, depicting part
of the A subunit, in particular residues 29–37.
The interaction of Lys213 of the A2 subunit
with the carbonyl oxygens of Tyr29 and Gly32
are indicated by dashed lines. The Nz to
oxygen hydrogen bonds are 2.8 and 3.1 Å,
respectively. 
Table 2
Summary of refinement statistics. 
Resolution range (Å) 10–2.25
Unique reflections (F>2sF) 43 325
Protein atoms 5469
Solvent molecules 215
R-factor (%) 19.1
Rfree (%) (10–2.5 Å) 26.6
Rms coordinate error (Å)* 0.28
Rms deviation from ideality
bonds (Å) 0.011
angles (°) 1.8
dihedral angles (°) 23.7
*Obtained from a Luzzati plot.
[30]. Our structure of LT-IIb was determined at pH 4.4,
being the first low pH structure to be reported for a
member of the CT family. The fact that our structure is
very similar to those of CT and LT-I, determined at
neutral pH, supports the observation that a low pH is not
required for A-subunit translocation and processing.
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Figure 2
The structures of LT-IIb and LT-I. The A1
subunit is shown in gold and the A2 subunit in
yellow. LT-IIb (left) and LT-I (right) holotoxins
[3,4] are viewed such that their B pentamers
are in a similar orientation. The individual B
subunits are in red, white, pink, green and
blue. The active-site region of each molecule
is highlighted by an asterisk and the
disulphide bond in the A subunit is indicated
by a black line. (Figure generated using
MOLSCRIPT [68].) 
Figure 3
Structures of the A and B subunits of LT-IIb
and LT-I. (a) Stereo diagram showing the
superposition of the A subunits of LT-IIb and
LT-I. LT-IIb is shown as thick lines while LT-I
[3,4] is shown as thin lines. The N and
C termini and the position of every twentieth
residue in the LT-IIb structure are labeled.
Also highlighted are residues 31 and 48
indicating the position of loops 24–34 and
45–54. The importance of these loops is
discussed in the text. The C terminus
indicated at position 230 is not the true
C terminus, as the last 13 residues were not
visible. (b) Stereo diagram showing the
superposition of the B subunit of LT-IIb and
LT-I [3,4]. The N and C termini and the
position of every twentieth residue in LT-IIb
are indicated. The disulphide bridges in both
B subunits are also shown, the cysteine
residues are shown in ball-and-stick
representation. The positions of residues 13,
14 and 92 are highlighted by white spheres:
their importance is discussed in the text.
The A subunit
The A subunit of LT-IIb is very similar to that of LT-I
(Fig. 3a). Superimposing LT-IIb (residues 2–23, 35–46
and 48–186) onto their equivalent residues in LT-I
results in a root mean square (rms) deviation of 0.77 Å for
173 Ca atoms, with a sequence identity of 64%. However,
the conformation of loop 24–34 in LT-IIb is substantially
different from the conformation observed in LT-I
(Fig. 3a). The significantly different loop conformation is
reflected in a much larger rms deviation of 4.49 Å for the
Ca atoms of these 11 residues, with the largest difference
being 6.2 Å. When comparing LT-IIb and LT-I loop
24–34 is 45% identical in amino acid sequence. The
precise cause of the large difference in conformation of
this loop is not obvious except for the fact that this stretch
of residues has diverged more in amino acid sequence
than the rest of the A1 subunit.
In the activation site of LT-IIb, the Cys185–Cys197 disul-
fide bridge is located at the same position as in LT-I. As in
LT-I, the cleavage site in LT-IIb is flexible, since
residues 188–194 could not be located in the electron-
density map. The conserved mobility in the cleavage loop
indicates that this flexibility is needed for proper proteo-
lytic cleavage and activation in heat-labile enterotoxins.
The overall temperature factor for the LT-IIb A1 subunit
is 24 Å2. This is lower than that observed in the LT-I
structure (38 Å2) [4]. There might be several reasons for
this observation such as differences in the inherent mobil-
ity of the A subunit, as well as differences in crystal
packing. However, the average temperature factors for
main-chain atoms per residue show a similar, but not iden-
tical, trend, as seen in the LT-I structure. 
The active site is located in a cleft on the A subunit
remote from the B pentamer (Fig. 2). The active site in
both CT and LT-I has been under investigation by means
of mutagenesis. Besides the critically conserved Glu112
[31,32], substitutions of the following residues have been
shown to affect ADP-ribosylation: Arg7, Asp9, His44,
Ser61, Ser63, Val97, Tyr104, Pro106, His107, Glu110 and
Ser114 [33–40]. The active site in LT-I is partially
occluded by a 10-residue loop comprising residues 47–56.
This loop in LT-I has been postulated to significantly
alter its position upon activation of the toxin in order to
accommodate NAD access to the active site [6]. In the
LT-IIb holotoxin structure, this loop is in a virtually iden-
tical location, also rendering the active site partially in-
accessible to the substrates (Figs 3a,4). Arg5 of LT-IIb,
which is equivalent to Arg7 in LT-I, is involved in identi-
cal interactions with this loop via two hydrogen bonds
formed with carbonyl atoms of Thr51 and Arg52. Arg7 in
LT-I has been proposed to have a dual function: to hold
loop 47–56 down in the AB5 holotoxin, thus rendering the
active site inaccessible, and to interact with NAD once
LT-I is activated and loop 47–56 has been reorganized [6]. 
The position and postulated interactions of the AMP and
nicotinamide moieties of NAD with the A subunit of
LT-IIb, as extrapolated from the ETA-complexed struc-
ture [41], are shown in Figure 4. Loop 45–54 is omitted
from the figure for clarity. The following specific interac-
tions are postulated to occur: First, the amide moiety of
nicotinamide is hydrogen bonded to the backbone oxygen
and nitrogen of Ala6; second, the ribose moiety of adeno-
sine forms hydrogen bonds with Arg5 and Asp7; third, the
adenine moiety interacts with the backbone oxygen of the
fully conserved Gly19 and with the nitrogen of Ile21;
fourth, Val14 provides a hydrophobic interaction with the
adenine ring. The binding mode of NAD in the active site
agrees well with the mutagenesis results carried out in
each of the toxins. 
The ETA structure, in complex with NAD fragments, [41]
highlighted two important stretches of residues (residues
12–14 and 19–22) which had not previously been included
in any of the published structure alignments performed on
the whole family of ADP-ribosylating toxins. The catalytic
residue Glu110 (which corresponds to Glu112 in LT-I and
CT) was the first residue known to be conserved through-
out this family. The structure-based sequence alignment,
as shown in Figure 5, reveals the presence of a second
fully conserved residue: the glycine at position 19 in the
LT-IIb sequence. In both the complexed structure of DT
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Figure 4
Schematic diagram showing the position of the AMP and nicotinamide
(Nic) moieties of NAD, within the active site of LT-IIb, and their
postulated interactions based upon similar interactions found with
these moieties in exotoxin A [40]. For clarity, residues comprising loop
45–54 are omitted in this figure; labels (45 and 54) have been placed
to indicate the beginning and the end of this loop. Some additional
minor structural adjustments, such as displacement of Arg9 (not
shown), are likely to occur to accommodate NAD binding. The catalytic
glutamic acid, Glu110, is also highlighted.
(with adenylyl 3′-5′ uridine 3′ monophosphate [ApUp]
[42]) and ETA (with NAD fragments [41]) this conserved
glycine adopts f and c angles (138° and 151° in DT, 105°
and 159° in ETA) which are energetically unfavorable for
any other amino acid. The corresponding f and c angles
for Gly19 in LT-IIb, which does not have an adenosine
fragment bound, are roughly similar (153° and –164°
respectively) to those angles observed in DT and ETA,
although not identical. The reason that a glycine is strictly
conserved at this position is most likely because the f and
c angles, which for all other residues are unfavorable, need
to be such that both the backbone oxygen and nitrogen
atoms are correctly oriented to make two important inter-
actions. The first of these interactions is a hydrogen bond
between the backbone oxygen and the N6 atom of the
adenine moiety of NAD (Fig. 4); the second is a hydrogen
bond between its backbone nitrogen and the backbone
oxygen of a valine residue (Val14 in LT-IIb). The second
interaction is present in all structures of the above-men-
tioned ADP-ribosylating toxins (LT-I, CT, DT, ETA),
pertussis toxin (PT) [43], and LT-IIb reported in this
paper. As described above, Val14 is postulated, based upon
the corresponding isoleucine residues in ETA and DT
(see Fig. 4), to be involved in a hydrophobic interaction
with the adenine ring of NAD. The sequence alignment in
Figure 5 shows that the variation of the chemical nature of
the residue at position 14 (of LT-IIb) is extremely limited
since in the family of ADP-ribosyltransferase toxins, only a
valine or an isoleucine is observed at this position. In con-
clusion, the NAD-binding mode in LT-IIb and LT-I, as
extrapolated from the AMP/nicotinamide/ETA structure,
is in good agreement both with mutagenesis data and the
conservation of the critical residues Gly19 and Val/Ile (at
position 14 of LT-IIb). Both these conserved residues are
involved in interactions with the adenine moiety of NAD,
throughout the toxin family ([44]; see note added in proof).
In LT-I a pathway of activation leading from the cleavage
site to the active site has been proposed to be mediated
via, sequentially, the A2 helix, loop 25–36 and loop 47–56
[6]. Two critical interactions in this putative cascade of
conformational changes in LT-I are conserved in LT-IIb:
the hydrogen bond between the main chain N of Arg23
with O of Tyr53; and the interaction between loop 24–34
and the A2 helix. However, the precise nature of these
interactions is substantially different in LT-IIb compared
with LT-I. Both the hydrophobic interactions (not listed)
and the hydrogen-bonding interactions are different,
because in LT-IIb Lys213 of the A2 helix interacts with
two carbonyl atoms of loop 24–34 (see Fig. 1b) while in
LT-I it is Gln215 that interacts with the carbonyl atom of
Tyr33 and Nh1 atom of Arg33 [6]. Although the proposed
conformational changes in [6] are speculative, the fact that
the nature of these two important interactions required for
the activation pathway is conserved in the new LT-IIb
structure strengthens this hypothesis.
Compared to LT-I and CT, LT-IIa and LT-IIb have a
lower affinity for model substrates such as the guani-
dinium-containing agmatine [19]. However, Gsa is a good
substrate for both the type I and type II enterotoxins. Con-
cerning a possible binding site for Gsa, it is noteworthy
that there is a stretch of residues which has been shown by
mutagenesis studies to be critical for enzymatic activity
[37,40]. These residues, Tyr104, Pro106, and His107, are
located on the other side of the active site crevice to the
residues we discussed in the previous paragraphs. Thus,
one could speculate that they are important for binding the
second substrate, Gsa. However, in the absence of an
A1–substrate complex, we refrain from attempts to explain
the substrate specificity similarities and differences based
on the latent LT-IIb and LT-I structures. 
B-subunit structure in the cholera toxin family
The striking similarity between the structures of the B sub-
units of LT-IIb and LT-I is evident from Figure 3b. A
superposition of 81 equivalent Ca atoms results in an rms
deviation of 1.6 Å. The internal disulfide bond between
Cys10 and Cys81 is located at the same position in LT-IIb
as in LT-I. The largest difference can be found in the
N terminus; in LT-IIb the N-terminal helix is almost a full
turn longer than that observed in LT-I. A structure- based
sequence alignment (Fig. 6) reveals that the sequence
identity is restricted to 11 out of 99 residues situated in
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Figure 5
Structure based sequence alignment of the
catalytic subunits of members of the ADP-
ribosyltranferase toxin family. Sequences are
aligned from porcine LT-I [4], CT [8], LT-IIa
(though no structure of this toxin is available
yet), LT-IIb, PT (pertussis toxin) [43], DT
(diptheria toxin) [42] and ETA (exotoxin A)
[41]. The two fully conserved residues are
shown boxed. The residues that are not in
structurally equivalent positions are not shown
in this figure.
pLTI    5LYRADSRPPDEI 16 21GLMP24 40NLYDHARG47 58GYVSTSLSLRSAHLA72 82TYYIYVIATA
CT      5............ 16 21....24 40........47 58......I.......V72 82..........
LTIIa   3FF.....T.... 14 19..L.22 38...E....45 56.....TVT..Q...I70 80E.....V.P.
LTIIb   3YF.....T...V 14 19..I.22 38........45 56.....TTT..Q...L70 80E.....V.A.
PT      7V..Y.....EDV 18 22.FTA25 31.VLE.LT.38 49AF....SSR.YTEVY63 85IG...EVRAD
DT    19S.HGT23 29.S. 31 34.IQK37 52 GFYSTDNKYD.AGY65 78 GGVVKVT 84
ETA  438G.HGT442 448QS.450 454.VRA457 468 GFYIAGDPAL.YGY481 496 GALLRVY502
pLTI   PNMFNVNDV100 109YEQEVSALGGIPYSQIYGWYRVN 131 139LHRNREYRD 147 153LNIAP 157
CT     .........100 109D.....................H 131 139.....G... 147 153.D... 157
LTIIa  ..L.D..G.88 107S.N.FA......L...I.....S 129 137MQ...D..G 145 151.TV.. 155
LTIIB  ..L.D..G.88 107S.N.YA......L...I.....S 129 137M....D..R 145 151.SA.. 155
PT     N.FYGAASS103 126.QS.YL.HRRI.PEN.RRVTRVY 148 160EYS.ARYVS 168 171TRAN. 175
DT     135VLS137 147 V.YINN152
ETA    541AIT543 552 L.TILG557
structurally equivalent positions. There are three gaps in
the LT-IIb structure when compared to the LT-I B sub-
unit, which is four residues longer. The structural similarity
between the LT-IIb and LT-I B subunits also extends
beyond the monomer B subunit. The superposition of the
B pentamers of these toxins results in an rms deviation of
1.9 Å for 5×81 Ca atoms. The B subunits in the two toxins
again provide an example of close structural similarities of
proteins without much correspondence in sequence.
The individual B subunits within the LT-IIb pentamer
are very similar to each other: the rms deviation between
the structures ranges from 0.24 to 0.34 Å for Ca atoms.
The largest differences are observed near residue 33, a
region with high thermal mobility resulting in poor elec-
tron density in 4 out of 5 B subunits. Despite these differ-
ences, the individual B subunits of LT-IIb are very similar
to each other in structure and have great similarity in
thermal motion (not shown).
Receptor binding of LT-IIb
Concerning the binding site for the receptor of LT-IIb,
GD1a, several lines of evidence point to a region similar 
to the ganglioside-binding pocket in LT-I. First, the
hydroxyl atoms of both Thr13 and Thr14 have been found
critical for GD1a affinity [45]; second, the postulated GD1a
binding site is in agreement with the location where most
proteins with the oligonucleotide/oligosaccharide-binding
fold (OB-fold) bind their nucleotide or saccharides [46];
third, Thr13 and Thr14 are located in a loop lining a
pocket with Trp92 located at the base of the pocket
(Fig. 7a), a feature that has been observed in LT-I as well
as in other galactose-binding sites [5]. In LT-I it is Trp88
that provides an important hydrophobic interaction with
the hydrophobic side of the galactose moiety of GM1. The
single tryptophan residue in LT-I and LT-IIb are sequen-
tially not in equivalent positions, as the Ca of Ser83 in LT-
IIb occupies the position equivalent to the Ca of Trp88 in
LT-I (Fig. 7b). Nevertheless, structurally, the side chains
of the tryptophan residues are in an identical location,
although they have different orientations (Fig. 7b). The
presence of the hydrophobic face of Trp92 in close proxim-
ity to Thr13 and Thr14 forming a pocket suggests that this
concave protein region is involved in recognition of GD1a.
On the basis of the unliganded structure of LT-IIb, it
seems that Thr13 and Thr14 have different roles in main-
taining the ability of LT-IIb to bind GD1a. The hydroxyl
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Figure 6
Structure based sequence alignment of the
B subunits of members of the AB5 toxin family.
Sequences are aligned from LT-IIb, LT-IIa,
human LT-I1, human LT-I2 (with the
His13→Arg mutation), porcine LT-I, CT1
(E1 Tor strain), CT2 (classical strain) and
verotoxin-1 (VT1). Sequences were taken
from [69]. The residues which form the
solvent accessible pore are shown in yellow
and the residues that form the hydrophobic
core within a single B subunit are in green.
The subset of pore residues, that form the
hydrophobic region of the pore, are shown in
boxed regions and the residues that are at the
conserved B–B interface in LT-IIb are
indicated by a ‘^’ symbol. The N-terminal helix
is not included in the residue classification
since this helix is not present in VT1. The
secondary structure symbols are indicated
above the sequence according to the LT-IIb
structure. Residues found in structurally
equivalent positions in the corresponding
crystal structures are underlined (for the Shiga
toxin [SHT] B subunit, coordinates of VT1
[70] were used instead of the SHT
coordinates as the latter are not available in
the PDB). The residues that are not
structurally equivalent are also included in this
figure to show the composition and length of
these loop residues. 
α1
β2 β3 β4
β5α2 β6
β1
              ^^^ ^^^ ^ ^^ ^^  ^                 ^^^^
       1             11  
LTIIb  GASQFFKDNCN
LTIIa  GVSEHFRNICN
hLTI1   APQSITELCS
hLTI2   APQSITELCS
pLTI    APQTITELCS
CT1     TPQNITDLCA
CT2     TPQNITDLCA
       
                     21              31            41            51
LTIIb  RTT-ASLVEGV--ELTKYISDINNNTDGMYVVSSTGGVWRISRAKD--  
LTIIa  QTT-ADIVAGV--QLKKYIADVNTNTRGIYVVSNTGGVWYIPGGRD--  
hLTI1  EYHNTQIYT-INDKILSYTESMAGKREMVIITFKSGATFQVEVPGSQH
hLTI2  EYRNTQIYT-INDKILSYTESMAGKREMVIITFKSGATFQVEVPGSQH
pLTI   EYRNTQIYT-INDKILSYTESMAGKREMVIITFKSGETFQVEVPGSQH
CT1    EYHNTQIYT-LNDKIFSYTESLAGKREMAIITFKNGAIFQVEVPGSQH
CT2    EYHNTQIHT-LNDKIFSYTESLAGKREMAIITFKNGATFQVEVGSQH
VT        TPDCVT-G--KVEYTKYND---DDTFTVKVG-DKELFTNR
                              
        
                61            71             81            91
LTIIb  -YPDNVMTAEMRKIAMAAVLSGMRV-NMCASPASSPNVIWAIELEAE
LTIIa  -YPDNFLSGEIRKTAMAAILSDTKV-NLCAKTSSSPNHIWAMELDRES
hLTI1  IDSQKKAIERMKDTLRITYLTETKIDKLCVWNNKTPNSIAAISMEN
hLTI2  IDSQKKAIERMKDTLRITYLTETKIDKLCVWNNKTPNSIAAISMEN
pLTI   IDSQKKAIERMKDTLRITYLTETKIDKLCVWNNKTPNSIAAISMKN
CT1    IDSQKKAIERMKDTLRIAYLTEAKVEKLCVWNNKTPHAIAAISMAN
CT2    IDSQKKAIERMKDTLRIAYLTEAKVEKLCVWNNKTPHAIAAISMAN
VT     --------WNLQSLLLSAQITGMTV -TIKTNACHNGGGFSEVIFR
                       ^^^^^^      ^
group of Thr14 is solvent accessible, indicating that its
importance is most likely in a direct or solvent-mediated
interaction with GD1a. Thr13, however, is involved in the
formation of two hydrogen bonds with O of Cys10 and N
of Ala15, suggesting a role in maintaining the structural
integrity of important residues at the GD1a binding site. In
addition, the importance of conformational changes of
LT-IIb upon receptor binding should not be ignored. For
example, upon binding GM1 or fragments thereof, loop
51–60 becomes tightly ordered in LT-I [5,7]. 
Receptor binding of LT-IIa
The close sequence similarity of LT-IIa and LT-IIb
allows an analysis of LT-IIa substitutions which affect the
receptor-binding site in LT-IIa. In LT-IIa, receptor
recognition is less specific than for LT-IIb as LT-IIa rec-
ognizes a larger variety of gangliosides, including GD1b,
GD1a, and GM1 [20]. At least two gangliosides, GM1 and
GD1b, were shown to compete with each other, suggesting
that they have spatially overlapping binding sites in
LT-IIa [47]. Thr13 and Thr34 were found to be important
for GD1b, GD1a, and GM1 binding in LT-IIa [47]. Thr14
was also found to be critical for GD1a and GD1b recognition,
but it was less involved in GM1 binding as a Thr14→Ile
variant still maintained GM1-binding activity. Thr34 in
LT-IIa seems to have a structural role, because mutations
at this site cause a low efficiency of assembly as well as a
loss of ganglioside binding [47]. This structural role is con-
firmed in the LT-IIb structure, as Thr34 makes two
hydrogen bonds with Od1 of Asp29 and with Nd2 of
Asn33. In contrast, Thr34 in LT-IIb is not critical for GD1a
binding [44]. Thus, the receptor-binding sites in LT-IIa
and LT-IIb are at the same location on the B pentamer,
with critical roles being played by Thr13 and Thr14.
The remarkable differences in ganglioside specificity
between LT-IIa and LT-IIb were studied using chimeric
proteins that combine sequences from LT-IIa and LT-IIb
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Figure 7
Receptor binding site. (a) Stereo diagram
showing the putative GD1a binding site
located in the B subunit. The critical residues
Thr13 and Thr14 are indicated. Trp92 and
other neighboring residues are also shown.
The figure shows two adjacent B subunits,
one colored blue and the other purple.
Sulphur, oxygen and nitrogen atoms are
represented as yellow, red and blue spheres,
respectively. (b) Stereo diagram showing a
close-up of the galactose binding site of LT-I
and the proposed ganglioside binding site of
LT-IIb after superposition of the B subunits.
LT-I is shown in dark ball-and-stick
representation while LT-IIb is shown in white
ball-and-stick. Trp88 and Trp92 of LT-I and
LT-IIb, respectively, are highlighted. The
residues at the equivalent position of these
tryptophans in LT-IIb and LT-I are Ser83 and
Ala97, respectively.
[45]. The N-terminal residues (1–53) of LT-IIa were
found to determine the broader binding specificity for
GD1b, GD1a, and GM1, whereas residues 1–70 of LT-IIb
determine the narrower binding specificity for GD1a [45].
In light of these results, and to further address the issue of
the differences in ganglioside specificity, 13 residues
found in close proximity to the putative ganglioside GD1a
binding pocket of LT-IIb (Fig. 7a) were compared with
the corresponding residues in LT-IIa [10,11]. It appears
that 7 out of 13 of these residues are different in LT-IIa,
with major differences at positions 48, 51 and 83 and more
conservative changes at positions 30, 32, 50 and 52. All but
one of these differences are situated within the aforemen-
tioned N-terminal region that determines the ganglioside
specificity. Though the precise nature of the interactions
of the two LT-IIs with their corresponding receptors still
needs to be confirmed by other experiments, all the avail-
able evidence points to the ganglioside-binding site of
LT-IIb to center around Trp92 (Fig. 7a).
Association of the A subunit with the B pentamer
Most interestingly, the mode of association of the
A subunit with the B pentamer of LT-IIb is substantially
different from that seen in the LT-I structure [3,4]. In
LT-IIb the A2 helix continues as a helix into the pore,
ending in the middle of the pore at residue 229 (Fig. 8). In
LT-I, however, the A2 helix approaches the B pentamer
from a different angle than that observed in LT-IIb. This
different angle does not allow the A2 helix to extend into
the pore of LT-I. Instead, the A2 polypeptide continues
into the pore as an extended chain followed by a small
helix at the other end of the pore [3,4] (Fig. 8). The
residues forming the pore in LT-IIb are almost all differ-
ent from those which form the pore in LT-I (Figs 6,8).
In LT-IIb, residue 230 is not part of the helix and residues
231–243 could not be fit in the uninterpretable electron
density present in the lower half of the pore. The interac-
tions between A2 and the B pentamer in the upper part of
the pore are entirely hydrophobic in nature by means of
Phe220, Thr221, Leu222, Met223, Thr224, Leu225,
Leu226, and Ile228 of A2 interacting with Met69, Ala70,
Leu73 and the Cb of Ser74 of each of the B subunits. In
fact, upon A2–B5 association, a surface of 1127 Å2 is
buried, of which 869 Å2 is hydrophobic. None of these
A2–B interactions in LT-IIb are conserved in LT-I. The
sequence of the part of the LT-IIb A2 chain which inter-
acts with the B subunit bears hardly any sequence identity
to that of LT-1 except for Lys217 and Arg218, which are
located just above the pore in both enterotoxins (Fig. 8).
The interactions of these two residues are different in LT-
IIb and LT-I. In the middle of the pore there are several
specific interactions observed between the A2 chain of
LT-IIb and its B pentamer. Interestingly, all hydrogen-
bond interactions are provided by the Nz atom of Lys66
from three different B subunits which interact with five
different oxygen atoms of the A2 subunit (Fig. 8).
The lower part of the pore holds the remaining 13 C-ter-
minal residues, for which some electron density is present.
Since the last interpretable residue (Asn230) is already
two-thirds of the way down the 30 Å long pore (Fig. 8), it
seems likely that not all 13 remaining residues will fit
inside the lower part of the pore. The four C-terminal
residues  lysine, aspartate, glutamate, leucine (KDEL) in
the A2 fragment of LT-IIb, being an endoplasmic reticu-
lum (ER) retention signal [48], will thus most likely
extend outside the pore, similar to the arginine, aspartate,
glutamate, leucine (RDEL) terminus in LT-I [3,4]. The
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Figure 8
Close-up view of the A2 chains of LT-IIb and
LT-I inside their corresponding B pentamer
pore. LT-IIb is shown on the left, and LT-I [3,4]
on the right. For clarity, only two of the five
B subunits (B1 and B3) are shown, the B
subunits are shown in blue and yellow for LT-
IIb and LT-1 respectively. The model of LT-IIb
A2 stops at residue 230 although some
electron density could be observed lower in
the channel for part of residues 231–243 of
the A2 chain. In LT-I, the last four residues
(237–240) of the A2 chain are also not
shown as no electron density could be
located for these residues. The A2 chain is
shown in orange, while the A1 subunit is in
red. Important residues involved in the A2–B
pentamer interaction are indicated. 
B1
LT-IIb
Met69
Leu73
Ser74
Ala70
Ala62
Lys66
Asn58
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B3
Glu63
A2
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Arg218
A1
B1
LT-I
Arg73
Leu77
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Glu66
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Ile74
A1
Thr78
Lys219
Arg67
Lys63
Arg220
B3
equivalent KDEL sequence in CT is also located just
outside the opening of the pore [8]. The involvement of
the ER retention signal in LT intoxication has been pos-
tulated.  However, recent studies have reached different
conclusions concerning the role of RDEL/KDEL-depen-
dent retrograde transport through the Golgi-ER during
intoxication by CT and LT-I [49,50].
A common feature of pores in the AB5 toxin family
The sequence comparison shown in Figure 6 highlights the
residues forming the pore in all B5-containing toxins. The
bottom half of the pore, comprising residues 59, 62, 63 and
66 in LT-IIb, seems to be highly polar in all toxins with
many charged residues pointing into the pore. The  excep-
tion is Shiga toxin (SHT), which has polar but no charged
residues. Clearly, the nature and distribution of the polar
and charged residues in the lower half of the pore are not
conserved and are completely different in various members
of the toxin family. Surprisingly, in all toxin structures
solved so far, not many specific interactions are made inside
the pore between the linker of the A subunit and this
hydrophilic lower half of the pore. In SHT [51] and LT-
IIb, residues within this linker are too disordered in the
bottom region within the pore to be modeled completely. 
The upper region of the pore, however, comprises a con-
served ring of hydrophobic residues present in all AB5 toxin
structures solved to date (Table 3). The solvent accessible
hydrophobic surface in the upper region of the pore is large
in all toxin pentamers (approximately 450–660 Å2). Con-
cerning the conserved hydrophobic region of the pore, the
presence of the hydrophilic Ser42 in SHT and VT is the
only exception within the AB5 toxin family, giving rise to a
somewhat smaller overall, but still dominant, hydrophobic
accessible surface in VT compared to the other members of
the family. The AB5 complex formation of LT-IIb makes
almost full use of this hydrophobic surface by complement-
ing it with a hydrophobic region of the A2 helix, thus
almost doubling the amount of buried hydrophobic surface
mentioned above. Residue 74 of the B subunit of LT-IIb,
which in all toxins is either serine or threonine (Fig. 6), is
special as its Og atom is always involved in a hydrogen
bond with the carbonyl oxygen of the residue one turn
further down the central helix. This leaves the hydropho-
bic atom(s) of the serine and threonine residues at this
position (residue Ser74 in LT-IIb and Thr78 in LT-I)
pointing towards the interior of the pore (see Fig. 8). 
The conserved ring of hydrophobic surface in the upper
region of the pores within the diverse family of AB5 toxins
is intriguing. The interactions at the top part of the pore
consist of a mainly hydrophobic area of the A2 helix inter-
acting with the ring of hydrophobic residues at the top 
of the pore. Though it is not immediately obvious, there
are several potential reasons why this feature might be
conserved and they will be discussed individually.
Overcoming the non-fivefold symmetry of the A2 chain
Since hydrophobic interactions are not usually very direc-
tion sensitive, the hydrophobic upper region within the
pore allows the non-fivefold linker to interact with a pore
possessing fivefold symmetry. In SHT [51], LT-IIb, and
to a lesser extent LT-I, this interaction is achieved by
means of a helix, with variable length, which is mainly
hydrophobic. In LT-IIb and SHT [51] about 1130 and
1000 Å2 of surface area are buried respectively, by inser-
tion of the helix into the pore. The amount of solvent
accessible surface area buried in LT-I in just the upper
region of the pore (by A2 residues upto Ser228 [4]) is
1020 Å2, of which 664 Å2 is hydrophobic. Since the A2
helix in LT-I barely enters the pore, and A2 continues
down the pore in an extended chain conformation, the
amount of hydrophobic surface buried in the upper region
of the pore is significantly smaller than in LT-IIb,
although it is still substantial.
AB5 assembly
The assembly of CT and LT-I holotoxin has been postu-
lated to involve intermediates such as AB3 and/or AB4 [52].
The A subunit was found to only associate with B subunits
that were in the process of assembling, and not with fully
assembled B pentamers [53]. Such an assembly pathway
has not yet been studied for LT-IIa, LT-IIb and SHT,
their in vitro AB5 assembly under non-denaturing condi-
tions is possible but with a low efficiency [54,55]. The
more efficient assembly in vivo of the latter toxins will
thus most likely also involve association of the A subunit
with B subunits that are not fully assembled B pentamers.
The B3 or B4 subunit folding intermediate might thus
attract the A subunit such that the partial hydrophobic
ring at the upper part of the incomplete pore interacts
with the hydrophobic part of the A2 linker. The middle
and lower parts of the long central helices of the B sub-
units might be involved in more specific hydrophilic inter-
actions with the A2 linker in these AB3 or AB4 assembly
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Table 3
Solvent-accessible molecular surface: comparison of the upper
region of the B-pentamer pore in related toxins.
Toxin Solvent- Solvent- Residues involved
accessible accessible
hydrophobic hydrophilic
surface (Å2) surface (Å2)
LT-IIb 494 0 Met69, Ala70, Leu73, Ser74
LT-I 658 5 Ile74, Leu77, Thr78
CT 549 25 Ile74, Leu77, Thr78
VT/SHT 449 117 Leu41, Ser42, Ile45, Thr46
The solvent accessible surface for the side chains forming the pore in
the pentamer of LT-IIb and LT-I (PDB code 1LTS) were calculated after
omitting the A subunit from the coordinate set. CT (PDB code 1CHB),
and VT (PDB code 1BOV) B pentamers were used and all water
molecules were omitted in the calculations. The program MSCON [67]
was used for the solvent-accessible molecular calculations.
intermediates. It has also been suggested that the interac-
tions of the A subunit with the not fully assembled B sub-
units enhance the stability of the assembly intermediate
in LT-I [53], thus resulting in the ability of its A subunit
to accelerate the rate of B subunit pentamerization. The
toxin AB3 or AB4 assembly intermediates can now attract
single B subunits to favourably complement the remain-
ing part of the exposed hydrophobic A2 helix with the top
part of their central B subunit helix: additional B–B and
B–A2 subunit interactions complete the assembly process.
In conclusion, we propose that the hydrophobic ring
present in the upper region of the pore in all AB5 toxins is
conserved since it can facilitate interaction of a fivefold
symmetry containing molecule with a non-fivefold sym-
metric, yet helical and hydrophobic, A2 linker. We also
propose that the hydrophobic ring aids in the in vivo AB5
assembly involving AB3 and/or AB4 intermediates.
Hybrid toxins
The above mentioned similarities and differences concern-
ing the A2–B5 interactions within the family of AB5 toxins
may explain the results observed in in vivo complementa-
tion studies with A and B subunits from type I and type II
enterotoxins. A subunits of LT-IIa and LT-IIb are able to
form hybrid toxins in vivo with B subunits of LT-I,
although with low efficiency [54]. This is remarkable, as the
sequence similarity in the A2 region between the type II
and the type I heat-labile enterotoxins is very limited. The
A2 chain of LT-IIa or LT-IIb is thus able to assemble not
only with its own B pentamer but also with the B pentamer
of LT-I that has only 11% sequence identity and signifi-
cantly different pore characteristics. However, as the major-
ity of the interactions between the A2 helix and the B
pentamer in LT-IIb holotoxin involve non-specific but
complementary hydrophobic interactions in the conserved
upper region of the pore, it seems likely that such interac-
tions also occur in the hybrid toxin formed by an A subunit
of LT-II and a B subunit of LT-I.
The ‘inverse’ hybrid, consisting of the A subunit of LT-I
and the B subunit of either LT-IIa or LT-IIb, did not
assemble in vivo [54]. As described above, the A2 linker of
LT-I does not complement the hydrophobic surface
within the pore of B5 as efficiently as the A2 linker of LT-
IIb. The A2 fragment of LT-I in this region is much more
hydrophilic than that of LT-IIb. Instead the A2–B5 inter-
actions in LT-I holotoxin are spread throughout the entire
length of the pore, involving more interactions unique to
LT-I. With this in mind, the inability of the LT-I A
subunit to associate with B pentamers of LT-IIa and LT-
IIb is not surprising. 
Hybridization studies using AB5 bacterial toxins have also
been successfully carried out with toxins that are more
homologous than LT-I and LT-II. The A and B subunits
of Shiga-like toxin-I (SLT-I) and SLT-II in vitro can,
under denaturing conditions, be assembled into hybrid
toxins [56]. Likewise, A subunits of SHT and SLT-I can
both form hybrid toxin in vivo with B subunits of SLT-II
and SLT-IIv [57]. In addition, hybrid toxins between LT-
I and CT have been obtained both in vivo and in vitro
under denaturing conditions [53,58] as well as hybrids
between LT-IIa and LT-IIb, again both in vivo and
in vitro under non-denaturing conditions [54]. In all these
hybrid holotoxins, the residues involved in the A–B5 inter-
face are not fully conserved compared to the correspond-
ing wild type holotoxins. Taken together, the results
obtained with assembly of hybrid toxins in several
systems described above, suggest that the AB5 assembly
process is quite promiscuous. This is in agreement with
the fact that the upper hydrophobic part of the pore is
common to, and plays a crucial role in assembly in all
these pore-containing AB5 toxins.
Conserved hydrophobic core of B subunits among the AB5
toxin family
The CT family (consisting of CT variants, LT-I variants,
LT-IIa and LT-IIb) are members of a large family of so
called ‘AB5 toxins’ [59,60] including pertussis toxin (which
is not included in the sequence alignment in Figure 6
since it contains a hetero B pentamer), SHT and SLT
(also called verotoxin). Figure 6 highlights the positions
(shown in green) that are part of the common hydrophobic
core in the B subunits of the structures solved so far in the
AB5 toxin family. Although not a single residue is con-
served in all of the sequences, the hydrophobic nature of
these residues forming the core is highly conserved. The
conservation of hydrophobicity is less noticeable in the
B–B interface residues (Fig. 6) than in the residues
forming the core of a single B subunit. The structure
based sequence alignment of the quite divergent B sub-
units of members of the AB5 toxins reveals the presence of
a conserved hydrophobic core, and might be useful in the
identification of future members of the AB5 toxin family
that contain B subunits with a similar fold.
Biological implications
The heat-labile enterotoxin family consists of ADP-ribo-
sylating toxins with an AB5 structure. These toxins
elevate cAMP levels by activating adenylate cyclase in
the small intestine of susceptible animals, thereby induc-
ing the secretion of fluids and electrolytes resulting in
diarrhea. Cholera toxin (CT) and the type I heat-labile
enterotoxins (LT-I) of E. coli are antigenically related
whereas the type II heat-labile enterotoxins of E. coli
(LT-II) are antigenically distinct from the type I entero-
toxins. Although CT and LT-I have been clearly
demonstrated to be significant causes of diarrhea, the
role of LT-II in diarrheal diseases of humans and other
animals has not yet been established. The catalytic 
A subunit of LT-IIb, like CT and LT-I, activates
Research Article Crystal structure of LT-IIb van den Akker et al. 675
adenylate cyclase by ADP-ribosylation of a G protein
subunit, Gsa. The structure of LT-IIb at the atomic
level can aid in understanding the still unknown ADP-
ribosylation mechanism of the toxin family. In addition,
the fact that the quaternary structure of LT-IIb closely
resembles that of LT-I and CT advances our under-
standing of the folding of the individual polypeptides and
in particular the assembly into AB5 holotoxin.
The structure of the catalytic domain of LT-IIb is very
similar to the catalytic domain structures of LT-I and
CT. This is in agreement with their 60% sequence iden-
tity, but the close structural similarity also suggests that
the low pH of 4.4 used for LT-IIb crystallization, does
not alter the active site in the A subunit. 
The B subunit of LT-IIb, which is responsible for recog-
nition of the ganglioside GD1a receptor, adopts a fold
similar to that of LT-I and other members of this toxin
family, despite the very limited sequence identity of 11%.
In AB5 type toxins B subunits come together to form a
doughnut shaped pentamer with a central pore. The
ganglioside receptor binding sites in LT-IIb are in a
similar region of the pentamer to the receptor-binding
sites in LT-I and CT. Comparison of all known toxin
pentamer structures revealed the presence of a con-
served hydrophobic ring of solvent accessible surface in
the upper region of the pore. This finding offers a struc-
tural explanation for the observation that certain combi-
nations of A and B subunits from type I and type II
enterotoxins are able to form hybrid toxins. We propose
that this hydrophobic upper half of the pore plays a
crucial role in AB5 assembly in the periplasm of the
pathogens producing these toxins. Clearly, the B pen-
tamers of the cholera toxin family are the result of diver-
gent evolution during which the ring-like shape of the B
pentamer, the general position for recognizing carbo-
hydrate moieties of receptors, and the hydrophobic
upper part of the pore have all been conserved as crucial
common features.
Materials and methods
Protein purification and crystallization
Previous methods [16] were improved by using a recombinant bacter-
ial strain and richer growth medium to overproduce LT-IIb and by modi-
fying the purification procedures. Plasmid pTC100 contains a 1.68
Kbp BglII-HpaI fragment, from pCP4185 encoding LT-IIb [11], ligated
into pBluescript KS+. The LT-IIb operon is oriented so that it can be
expressed from the strong lac promoter of the vector. In a representa-
tive experiment, E. coli HB101 (pTC100) was grown at 37°C and
250 rotations per min (rpm) to an optical density at 600nm
(OD600)=1.4. The culture was grown in 4 l Erlenmeyer flasks contain-
ing 1 l amounts of medium (35 g tryptone, 20 g yeast extract, 5 g
NaCl, 75 mg ampicillin and 50 mg kanamycin per l at pH 7.5). Iso-
propyl-b-D-thiogalactopyranoside (IPTG) was added to each culture at
0.5 mM final concentration, and incubation was continued for an addi-
tional 19 h. All further procedures were performed at 4°C. The bacteria
from 12 flasks (112 g wet weight) were collected by centrifugation
and disrupted by sonication. The purification scheme involved ammonium
sulfate precipitation at 60% saturation, ion exchange chromatography
on DEAE-cellulose, chromatofocussing on PBE94, and gel filtration
chromatography on Sephadex G100. The final yield of purified LT-IIb
was 88 mg at 8.8 mg=ml–1, and the purified LT-IIb appeared homoge-
neous as assessed by SDS-page. LT-IIb was then concentrated to
about 10 mg=ml–1 using the Centricon system (10 kDa). LT-IIb was
crystallized using the sitting drop method from 2.0 M NaCl, 0.2 M
Li2SO4, 0.2 M sodium acetate buffer at pH 4.7 and 4°C. The final pH
of the reservoir is pH 4.4. Data collection size crystals grew in about
2–3 months with a smallest dimension of about 0.15 mm.
X-ray diffraction data
The first native data set and the Pt-derivative data set were collected at
room temperature from a single crystal on an RAXIS-II image plate
detector and processed using RAXIS-software from Molecular Struc-
ture Corporation (The Woodlands, Texas). The second native dataset
was collected at the CHESS synchrotron facility to higher resolution,
integrated using DENZO and scaled using SCALEPACK [61,62]
(Table 1). This data set was used for the final stages of refinement. The
spacegroup of the LT-IIb crystals is P3121 with cell dimensions
a=b=105.7 Å and c=171.6 Å. 
Structure determination
An LT-IIb crystal was soaked for 24 h in a mother liquor containing
10 mM K2PtCl4. The derivative dataset was scaled to the native data
set using KBRANI (WGJH and SC Mande, unpublished program). The
first major platinum site was calculated by hand and verified using
RSPS [63] and VSFUN4 (WGJH, unpublished program). The other six
sites were determined using the cross search mode in RSPS as well
as by calculating a cross difference Fourier using phases obtained from
MLPHARE [64] with the single Pt site. Finally, all seven positions were
refined using MLPHARE first with data from 15–5 Å resolution (Table
1) and later extended to 4.0 Å. Five of the seven atoms had inter Pt dis-
tances and angles that followed fivefold symmetry with two indepen-
dent sites per B subunit. One site had three out of five possible
platinum atoms bound and the other site had only two out of five bound
per pentamer. A 5 Å resolution electron-density map using phases cal-
culated from the Pt derivative, with an overall figure of merit of 0.34 for
acentric reflections (without anomalous data), revealed five long rods
along a fivefold axis which coincided with the fivefold axis obtained
from the Pt sites (Fig. 1a). Also the A2 helix was clearly visible in this
map (Fig. 1a). The helices from the B pentamer of LT-I surprisingly
matched the five rods of density including their angle with the fivefold
axis. It was this angle of the five rods with the fivefold axis with respect
to the position of the A subunit that helped in determining the correct
spacegroup enantiomer, P3121. Solvent flattening and histogram
matching using DM (K Cowtan, unpublished program) was used to
improve the quality of the 5 Å map. Next, a polyalanine model of the LT-
I B pentamer was placed in density as well as a homology model of the
A subunit based upon the LT-I structure. O [65] was used to build this
homology model, consisting of the A1 subunit and the helix portion of
A2. The Ca coordinates of the pentamer after rigid body refinement in
X-PLOR [26] were used to generate improved NCS operators. DM
was then used to phase extend from 4 to 2.9 Å resolution using solvent
flattening and histogram matching. IMP (GJ Kleywegt and TA Jones,
unpublished program) was used to refine the NCS using a mask of a
single B subunit yielding correlation coefficients of about 0.22. The
uninterpretable 2.9 Å map was averaged using MAMA (GJ Kleytwegt
and TA Jones, unpublished program) for 1 cycle. This averaged map
could readily be interpreted with the scaffold of the LT-I B pentamer as
a guide, assigning about 80% of the residues in the LT-IIb B subunit.
The partial model of the B pentamer as well as the coordinates of the A
subunit after the initial rigid body refinement were subjected to stan-
dard molecular dynamics, positional and individual temperature factor
refinement in X-PLOR. The new coordinates of the B pentamer were
used to obtain improved NCS operators to calculate an improved aver-
aged map. Fo–Fc and 2Fo–Fc maps were also calculated to model the
remaining parts of the structure using O. 
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Refinement
Initially the native data set 1 was used for refinement. 5% of the data
were set aside for the Rfree before refinement. Iterative cycles of model
building and refinement were performed as well as extending the resolu-
tion from 2.9 to 2.5 Å. PROCHECK [66] was used to identify residues
with geometric strain that needed to be rebuilt. 46 solvent molecules
were modeled with data from 10–2.5 Å resolution resulting in an 
R factor of 19.5% and an Rfree of 26.6 %. The 2.25 Å native data set 2
was then used to complete the refinement with all data included. 215
solvent molecules were modeled that had electron-density features
above 3s in a Fo–Fc map and appropriate hydrogen-bonding interactions
with the protein. At this point the crystallographic R factor was 19.7%. 
A final anisotropic overall B-factor refinement in X-PLOR brought the 
R factor to 19.1%. The six anisotropic B factor parameters were refined 
to the following values: U11=0.0410, U22=0.0410, U33=–0.0488,
U12=0.0117, U13=0.0000, U23=0.0000. The anisotropy in the data
was already visible during data collection. The quality of the final model
was checked with PROCHECK, and the rms deviations from ideality are
listed in Table 2. The average rms deviation comparing the Ca coordi-
nates from the separate B subunits is about 0.29 Å. 
Accession numbers
The coordinates of LT-IIb have been deposited with the Brookhaven
Protein Data Bank (entry code 1TII).
Note added in proof
After submission of this manuscript a paper describing the NAD-
binding mode to DT and recognizing the conservation of Gly34, which
is the equivalent of Gly19 in LT-IIb as described in this paper, in the
family of ADP-ribosylating toxins has appeared in press [44]. 
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